Research Alliance Corporation III

Research Alliance Corporation III(RACC)股票分析

$10.160

+0.010 (+0.10%)收盘时

Loading chart…
最高
10.160
开盘
10.120
成交量加权均价
10.15
成交量
2.72K
市值
—
最低
10.120
成交额
27.62K
企业价值/息税折旧摊销前利润(TTM)
0.00

Research Alliance Corporation III is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has not selected any specific business combination.

AI 分析 of Research Alliance Corporation III (RACC)

持有

Research Alliance Corp III (RACC) is currently not a strong buy. The stock is trading at $10.10, significantly below its 52-week high of $33.50, indicating a potential for recovery but also a substantial risk. The RSI is at 37.048, suggesting it is nearing oversold territory, but the lack of positive momentum is concerning. The forward P/E ratio is currently at 0, indicating uncertainty in future earnings, and the recent net income shows volatility with a loss of $65,249 in Q1 2026 followed by a gain of $54,050 in Q2 2026. The main risk is the current ratio of 17.30, which, while indicating strong liquidity, follows a period of much lower ratios, suggesting instability. Overall, while there are potential upsides, the current indicators do not strongly support a buy at this moment.

估值指标

Research Alliance Corporation III(RACC)当前预期市盈率为 0.00,5 年平均预期市盈率为 。

预期市盈率

5 年均值 P/E
当前P/E
0.00

预期 EV/EBITDA

5 年均值 EV/EBITDA
当前EV/EBITDA
0.00

预期市销率

5 年均值 P/S
当前P/S
0.00

持有 RACC 的大户

T

TCG Crossover Management, LLC

+ 持有RACC

+127.89%

3个月收益率

V

VR Management, LLC

+ 持有RACC

+14.69%

3个月收益率

B

BVF Partners L.P.

+ 持有RACC

+8.72%

3个月收益率

事件时间线

2026-07-31 (ET)

10:30:00

Research Alliance Corporation III Trading Halted Due to Volatility Trading Pause

2026-07-27 (ET)

09:00:00

OHB Pediatrics and RACC Announce Business Combination Agreement

2026-06-30 (ET)

15:00:00

Research Alliance Corporation III Trading Halted Due to Volatility Pause

2026-05-26 (ET)

11:10:00

SpaceX Files for IPO Aiming to Raise $80 Billion

2026-05-20 (ET)

11:50:00

Research Alliance Prices IPO at $10.00 per Share

资讯

RACC 常见问题 —— 由 Alphio AI 解答

Research Alliance Corporation III is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has not selected any specific business combination. It operates in the Financials sector.

Research Alliance Corp III (RACC) is currently not a strong buy. The stock is trading at $10.10, significantly below its 52-week high of $33.50, indicating a potential for recovery but also a substantial risk. The RSI is at 37.048, suggesting it is nearing oversold territory, but the lack of positive momentum is concerning. The forward P/E ratio is currently at 0, indicating uncertainty in future earnings, and the recent net income shows volatility with a loss of $65,249 in Q1 2026 followed by a gain of $54,050 in Q2 2026. The main risk is the current ratio of 17.30, which, while indicating strong liquidity, follows a period of much lower ratios, suggesting instability. Overall, while there are potential upsides, the current indicators do not strongly support a buy at this moment.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易